Will a Phase III hantavirus vaccine trial report positive results in 2026?

Started: May 20, 2026

Ends

Dec 31, 2026

MTH

DAY

HRS

MIN

SEC

About this Market

Measures whether researchers announce a successful hantavirus vaccine trial globally.

0 traders/$0 total volume

No participants yet.

0 comments

No discussion yet.